Novonesis said on Tuesday that it had agreed to buy the stake of its partner, Swiss-Dutch chemical manufacturer DSM-Firmenich, in their joint enzymes venture for 1.5 billion euros ($1.55 billion). The ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results